Roflumilast
Roflumilast (trade names Daxas, Daliresp) is a drug which acts as a selective, long-acting inhibitor of the enzyme PDE-4. It has antiinflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs such as asthma, and chronic obstructive pulmonary disease (COPD).
RoflumilastPiclamilastFilaminastList of drugs: Rf-RzATC code R03Phosphodiesterase-4 inhibitorPhosphodiesterase inhibitorChronic obstructive pulmonary disease





Share this!